Eliana Rulli - Mario Negri Institute for Pharmacological Research

基本信息

浏览量：96

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 203 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Adjuvant Systemic Therapy in Early Breast Cancer and Results of a Prospective Observational Multicenter BRIDE Study: Patients Outcome and Adherence to Guidelines in Cancer Clinical Practice

Frontiers in oncology (2025): 1501667-1501667

引用0浏览0WOS引用

Tracking the Response to Immunotherapy: Blood Microrna Dynamics in Patients with Advanced Non-Small Cell Lung Cancer

Maria Vittoria Chiaruttini,Claudia Proto,Giuseppe Lo Russo,Arsela Prelaj,Miriam Segale, Anna Zanghì,Francesca Galli,Francesca G Greco,Diego Signorelli, Marta Brambilla,Mario Occhipinti, Filippo De Braud, Marina C Garassino,Gabriella Sozzi,Eliana Rulli,Mattia Boeri

JCO precision oncology (2025): e2400790-e2400790

引用0浏览0WOS引用

Efficacy and Safety of Ramucirumab Plus Carboplatin and Paclitaxel in Untreated Metastatic Thymic Carcinoma: RELEVENT Phase II Trial (NCT03921671)

C. Proto,M. Ganzinelli,S. Manglaviti,M. Imbimbo,G. Galli,M. Marabese, F. Zollo,M. F. Alvisi,M. Perrino, N. Cordua, F. Borea,F. de Vincenzo,A. Chella,S. Cappelli, E. Pardini,Z. Ballatore,A. Lucarelli,E. Ambrosini,M. Giuliano,E. Pietroluongo,C. Mulargiu,A. Fabbri,A. Prelaj,M. Occhipinti,M. Brambilla,L. Mazzeo,T. Beninato,R. Vigorito, M. Ruggirello,F. G. Greco,G. Calareso,D. Miliziano,E. Rulli, I. De Simone,V. Torri,F. G. M. de Braud,G. Pasello,P. De Placido,R. Berardi,I. Petrini,P. Zucali,M. C. Garassino,G. Lo Russo

ANNALS OF ONCOLOGYno. 9 (2024): 817-826

引用2浏览0WOS引用

Rising Concern about the Carcinogenetic Role of Micro-Nanoplastics

Lorenzo Ruggieri, Ottavia Amato, Cristina Marrazzo, Manuela Nebuloni,Davide Dalu,Maria Silvia Cona,Anna Gambaro,Eliana Rulli, Nicla La Verde

International journal of molecular sciencesno. 1 (2024)

引用0浏览0WOS引用

P1.06B.11 Plasma MicroRNAs Profiling to Monitor Immunotherapy Response in Advanced NSCLC Patients

C. Proto, M. V. Chiaruttini, A. Zanghi,G. Lo Russo,A. Prelaj, M. Segale,F. G. Greco,M. Brambilla,M. Occhipinti,T. Beninato,L. Mazzeo,R. Leporati,M. Ganzinelli,C. Giani,D. Miliziano, G. Di Liberti,G. Mazzoli,F. De Braud,M. C. Garassino,G. Sozzi,E. Rulli,M. Boeri

JOURNAL OF THORACIC ONCOLOGYno. 10 (2024): S170-S171

引用0浏览0引用

36MO Patient-reported Outcomes in Primary Advanced or Recurrent Endometrial Carcinoma Treated with Atezolizumab or Placebo in Combination with Carboplatin-Paclitaxel in the AtTEnd/ENGOT-EN7 Trial

Y.C. Lee,N. Colombo,K. Harano,E. Rulli, E. Hudson, K.B. Lee,M. Rabaglio,I. Braicu,E. Petru, Y-C. Ou,E. Biagioli,A. Redondo, K. Takehara, K. Allan,Y. Antill,M. Lapresa,E. Piovano, G. Tasca, C. Zamagni,M.P. Barretina Ginesta

ESMO Open (2024): 103536

引用0浏览0引用

Atezolizumab and Chemotherapy for Advanced or Recurrent Endometrial Cancer (attend): a Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial

LANCET ONCOLOGYno. 9 (2024): 1135-1146

引用6浏览0WOS引用

BRCA1 Foci Test As a Predictive Biomarker of Olaparib Response in Ovarian Cancer Patient-Derived Xenograft Models

Federica Guffanti,Ilaria Mengoli,Maria Francesca Alvisi,Giulia Dellavedova,Raffaella Giavazzi,Robert Fruscio,Eliana Rulli,Giovanna Damia

FRONTIERS IN PHARMACOLOGY（2024）

引用0浏览0WOS引用

Rising Concern about the Carcinogenetic Role of Micro‐Nanoplastics

Lorenzo Ruggieri, Ottavia Amato, Cristina Marrazzo, Manuela Nebuloni,Davide Dalu,Maria Silvia Cona,Anna Gambaro,Eliana Rulli, Nicla La Verde

crossref（2024）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn